Safety Shot, Inc.

About Safety Shot, Inc.

Safety Shot, Inc. is a company focused on innovative functional beverages, notably as the creator of Sure Shot, the world's first patented rapid alcohol reducer. Launched in Q4 2023 and rebranded in Q4 2024, their mission is to help people feel better faster by reducing blood alcohol content through metabolic support in as little as 30 minutes.

Products & Services

Sure Shot:The world's only clinically proven rapid alcohol reducer, lowering blood alcohol content by supporting its metabolism in minutes, not hours. A unique recovery beverage with no direct competitors.

Sure Shot:A patented rapid alcohol reducer, clinically proven to lower blood alcohol content by supporting metabolism in as little as 30 minutes, distinguishing it from competitors.

Specialties

Rapid Alcohol Reduction Recovery Beverages Clinical Trials and Research Functional Beverages Innovative Product Development

Funding History

No funding data available

This company may be bootstrapped or privately funded

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jarrett Boon

Chief Executive Officer

J

John Gulyas

CHAIRMAN OF THE BOARD

J

Jordan Schur

President

D

David Sandler

Chief Financial Officer

M

Markita Russell

Chief Financial Officer

D

David Long

Board Member

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

Safety Shot, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised